UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021911
Receipt number R000025273
Scientific Title Analysis and comparison of carboxyl esterase and trp channel expression in the skin of sensitive skin persons and atopic dermatitis patients
Date of disclosure of the study information 2016/04/15
Last modified on 2018/04/10 18:03:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis and comparison of carboxyl esterase and trp channel expression in the skin of sensitive skin persons and atopic dermatitis patients

Acronym

Analysis and comparison of enzymes in the skin of sensitive skin persons and atopic dermatitis patients

Scientific Title

Analysis and comparison of carboxyl esterase and trp channel expression in the skin of sensitive skin persons and atopic dermatitis patients

Scientific Title:Acronym

Analysis and comparison of enzymes in the skin of sensitive skin persons and atopic dermatitis patients

Region

Japan


Condition

Condition

atopic dermatitis

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Analysis and comparison of carboxyl esterase and trp channel expression in the skin of sensitive skin persons and atopic dermatitis patients

Basic objectives2

Others

Basic objectives -Others

no

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The expression of carboxyl esterase and trp channel

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

skin biopsy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The atopic dermatitis patient assumes it the person who had a diagnosis in department of dermatology, Hamamatsu university school of medicine.
We perform questionary survey over a telephone for 800-1000 volunteers about the physically unimpaired person with a sense stimulation sensitive person. We perform stinging examination for 180-190 people in hope of an examination. Based on stinging test result, we choose a subject.

Key exclusion criteria

1. A person with remarkable bleeding tendency.
2. A pregnant woman.
3. The person who has difficulty in self-judgment for dementia.
4. The person whom it was judged a doctor to be in condition to be easy to be accompanied by complications when it enforced skin biopsy.
5. A person during an immunosuppressant, the adrenocorticosteroid whole body dosage.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiki Tokura

Organization

Hamamatsu university school of medicine

Division name

Department of dermatology

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan

TEL

053-435-2303

Email

tokura@hama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masahiro Aoshima

Organization

Hamamatsu university school of medicine

Division name

Department of dermatology

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan

TEL

053-435-2303

Homepage URL


Email

maoshima@hama-med.ac.jp


Sponsor or person

Institute

Hamamatsu university school of medicine

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松医科大学皮膚科(静岡県)、花王株式会社安全性科学研究所、近藤皮膚科クリニック(東京都)


Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 02 Month 10 Day

Date of IRB


Anticipated trial start date

2017 Year 02 Month 01 Day

Last follow-up date

2017 Year 02 Month 28 Day

Date of closure to data entry

2017 Year 06 Month 30 Day

Date trial data considered complete

2018 Year 02 Month 28 Day

Date analysis concluded

2018 Year 02 Month 28 Day


Other

Other related information



Management information

Registered date

2016 Year 04 Month 14 Day

Last modified on

2018 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025273


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name